NEW YORK STATE COMMON RETIREMENT FUND - CUE BIOPHARMA INC ownership

CUE BIOPHARMA INC's ticker is CUE and the CUSIP is 22978P106. A total of 94 filers reported holding CUE BIOPHARMA INC in Q3 2020. The put-call ratio across all filers is 0.71 and the average weighting 0.3%.

Quarter-by-quarter ownership
NEW YORK STATE COMMON RETIREMENT FUND ownership history of CUE BIOPHARMA INC
ValueSharesWeighting
Q3 2023$28
-70.2%
11,984
-53.4%
0.00%
Q2 2023$94
-90.6%
25,700
+9279.6%
0.00%
Q2 2022$1,000
-98.9%
274
-98.5%
0.00%
Q1 2022$89,000
-56.6%
18,211
+0.3%
0.00%
Q4 2021$205,000
-22.9%
18,152
-0.4%
0.00%
Q3 2021$266,000
-11.0%
18,229
-28.9%
0.00%
Q2 2021$299,000
-3.5%
25,642
+1.0%
0.00%
Q1 2021$310,000
-2.5%
25,4000.0%0.00%
Q4 2020$318,000
-16.8%
25,4000.0%0.00%
Q3 2020$382,000
-38.7%
25,4000.0%0.00%
-100.0%
Q2 2020$623,000
+133.3%
25,400
+35.1%
0.00%
Q1 2020$267,000
-10.4%
18,8000.0%0.00%
Q4 2019$298,000
+227.5%
18,800
+74.1%
0.00%
Q3 2019$91,000
-6.2%
10,8000.0%0.00%
Q2 2019$97,000
+304.2%
10,800
+248.4%
0.00%
Q1 2019$24,000
+60.0%
3,1000.0%0.00%
Q4 2018$15,000
-91.6%
3,100
-84.3%
0.00%
Q3 2018$178,000
-23.9%
19,7000.0%0.00%
Q2 2018$234,00019,7000.00%
Other shareholders
CUE BIOPHARMA INC shareholders Q3 2020
NameSharesValueWeighting ↓
Prosight Management, LP 1,545,573$3,447,0001.85%
P.A.W. CAPITAL CORP 200,000$446,0000.67%
SANDERS MORRIS HARRIS LLC 848,048$2,020,0000.50%
Monaco Asset Management SAM 458,851$1,023,0000.39%
Bleichroeder LP 555,000$1,238,0000.26%
APOGEM CAPITAL LLC 110,614$247,0000.25%
Slate Path Capital LP 1,483,619$3,308,0000.22%
Voss Capital, LLC 200,000$446,0000.13%
Robertson Stephens Wealth Management, LLC 478,500$1,067,0000.11%
CARLSON CAPITAL L P 535,000$1,193,0000.09%
View complete list of CUE BIOPHARMA INC shareholders